Entrega

Biotech · Private

Oral delivery platform that converts subcutaneous biologics to oral administration

entrega.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
21
0 granted · 21 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3060RNA NANOTHERAPEUTICS LLC——
3061Parabolica Therapeutics, Inc.—$50K
3062Centessa Pharmaceuticals——
3063Entrega——
3064Nested Therapeutics——
3065ELSOHLY LABORATORIES, INC.——
3066490 BIOTECH INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 21
  • Oral Dosage Form With Ionically Chargeable Hydrogel For Delivery Of Active Agentapplication
  • Device For Oral Delivery Of Active Agentsapplication
  • Device For Oral Delivery Of Active Agentsapplication
  • Oral Dosage Form With Surface Delivery Of Active Agentapplication
  • Device For Oral Delivery Of Active Agentsapplication
  • Oral Dosage Form With Drying Agent For Delivery Of Active Agentapplication
  • Device For Oral Delivery Of Active Agentsapplication
  • Oral Dosage Form With Surface Delivery Of Active Agentapplication
  • Oral Dosage Form With Surface Delivery Of Active Agentapplication
  • Oral Dosage Form With Drying Agent For Delivery Of Active Agentapplication
  • Oral Dosage Form With Drying Agent For Delivery Of Active Agentapplication
  • Device For Oral Delivery Of Active Agentsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.